Dashboard
Manage Tickers

ENFN


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

enfusion-q1-2024-adj-eps-006-beats-004-estimate-sales-48052m-beat-47616m-estimate
Enfusion Q1 2024 Adj EPS $0.06 Beats $0.04...
05/09/2024 11:34:40

Enfusion (NYSE:ENFN) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.04 by 50 pe...

watching-enfusion-spruce-point-capital-management-issues-short-report-on-co-says-based-on-our-investigation-we-estimate-a-40-to-60-downside-risk
Watching Enfusion; Spruce Point Capital Ma...
03/14/2024 13:32:05

https://www.sprucepointcap.com/research/enfusion-inc After conducting a forensic review of Enfusion, a technology provider for ...

12-information-technology-stocks-moving-in-thursdays-pre-market-session
12 Information Technology Stocks Moving In...
03/14/2024 13:06:04

a-glimpse-into-the-expert-outlook-on-enfusion-through-4-analysts
A Glimpse Into The Expert Outlook On Enfus...
03/13/2024 14:04:11

b-of-a-securities-maintains-underperform-on-enfusion-raises-price-target-to-9
B of A Securities Maintains Underperform o...
03/13/2024 12:10:37

B of A Securities analyst Koji Ikeda maintains Enfusion (NYSE:ENFN) with a Underperform and raises the price target from $8 ...

enfusion-expects-2024-revenue-of-200m-210m-vs-2023m-est
Enfusion Expects 2024 Revenue of $200M-$21...
03/12/2024 12:14:02

Financial outlook 13 These statements are forward-looking and actual results may differ materially. Refer to the “Forward-Looki...

enfusion-q4-2023-adj-eps-004-misses-005-estimate-sales-46486m-beat-45275m-estimate
Enfusion Q4 2023 Adj EPS $0.04 Misses $0.0...
03/12/2024 12:05:50

Enfusion (NYSE:ENFN) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.05 by 20 ...

earnings-scheduled-for-march-12-2024
Earnings Scheduled For March 12, 2024
03/12/2024 09:35:47

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

earnings-outlook-for-enfusion
Earnings Outlook For Enfusion
03/11/2024 15:02:35

enfusion-stock-to-remain-range-bound-in-2024-amid-stable-hedge-fund-market-goldman-sachs-analyst-downgrades-stock
Enfusion Stock To Remain Range-Bound In 20...
02/28/2024 20:11:29

Goldman Sachs downgrades Enfusion from Neutral to Sell, lowers price target from $9 to $8, expects stock to be range-bound in 2...

goldman-sachs-downgrades-enfusion-to-sell-lowers-price-target-to-8
Goldman Sachs Downgrades Enfusion to Sell,...
02/28/2024 11:03:28

Goldman Sachs analyst Gabriela Borges downgrades Enfusion (NYSE:ENFN) from Neutral to Sell and lowers the price target from ...

jp-morgan-downgrades-enfusion-heres-what-you-need-to-know
JP Morgan Downgrades Enfusion: Here's What...
01/30/2024 17:00:32

jp-morgan-downgrades-enfusion-to-underweight-lowers-price-target-to-9
JP Morgan Downgrades Enfusion to Underweig...
01/30/2024 10:47:04

JP Morgan analyst Alexei Gogolev downgrades Enfusion (NYSE:ENFN) from Neutral to Underweight and lowers the price target fro...

this-analyst-with-84-accuracy-rate-sees-around-13-upside-in-darden-restaurants---here-are-5-stock-picks-for-2023-from-wall-streets-most-accurate-analysts
This Analyst With 84% Accuracy Rate Sees A...
01/02/2024 14:35:34

U.S. stocks closed slightly lower on Friday, but the S&P 500 closed out last year with a gain of 24.2%. The Dow closed the ...

piper-sandler-maintains-neutral-on-enfusion-raises-price-target-to-10
Piper Sandler Maintains Neutral on Enfusio...
12/20/2023 19:18:02

Piper Sandler analyst Sumeet Mody maintains Enfusion (NYSE:ENFN) with a Neutral and raises the price target from $9 to $10.

enfusion-announces-appointment-of-neal-pawar-as-coo-effective-nov-27
Enfusion Announces Appointment Of Neal Paw...
11/20/2023 13:16:40

ubs-initiates-coverage-on-enfusion-with-neutral-rating-announces-price-target-of-9
UBS Initiates Coverage On Enfusion with Ne...
11/07/2023 13:52:25

UBS analyst Kevin Mcveigh initiates coverage on Enfusion (NYSE:ENFN) with a Neutral rating and announces Price Target of $9.

enfusion-q3-eps-002-misses-005-estimate-sales-4436m-beat-4405m-estimate
Enfusion Q3 EPS $0.02 Misses $0.05 Estimat...
11/07/2023 12:39:28

Enfusion (NYSE:ENFN) reported quarterly earnings of $0.02 per share which missed the analyst consensus estimate of $0.05 by 60 ...

earnings-scheduled-for-november-7-2023
Earnings Scheduled For November 7, 2023
11/07/2023 11:34:30

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

goldman-sachs-maintains-neutral-on-enfusion-lowers-price-target-to-10
Goldman Sachs Maintains Neutral on Enfusio...
08/09/2023 15:45:59

Goldman Sachs analyst Gabriela Borges maintains Enfusion (NYSE:ENFN) with a Neutral and lowers the price target from $11.5 t...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION